Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT06440694
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Registry
-
NCT06440694
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Canada
- Registry status
- Recruiting
Technical summary
Registry record NCT06440694. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-07 (actual); primary completion 2027-12-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)
- Condition
- Venous Thromboembolism
- Intervention (Drug)
- Colchicine 0.5 mg po
- Intervention (Drug)
- Placebo 0.5 mg po
- Lead sponsor
- Ottawa Hospital Research Institute
Record details
- Record id
cardio:ct-nct06440694- Content hash
831a38f90910019da0df93d0d9a5adec0a16650c8936eee020aa34b7ec210453